Revenues grew 26.1% YoY to | 4812.8 crore (I-direct estimate: | 4587.1 crore) on the back of sale of three proprietary products (| 720 crore). EBITDA margins expanded 221.4 bps to 22.1% (I-direct estimate: 26.6%) mainly due to sale of proprietary products and lower R&D; spend. Delta vis--vis I-direct estimates was mainly due to an adverse product mix. EBITDA grew 40.1% YoY to | 1063.8 crore against I-direct estimate of | 1222.0 crore. Net profit grew 113.5% YoY to | 1106.8 crore (I-direct estimate: | 790.0 crore). Delta vis--vis EBITDA mainly due to lower tax outgo led by recognition of...